News | April 01, 2025
Shin-Etsu Chemical to invest in pharmaceutical cellulose business
L-HPC was independently developed by Shin-Etsu Chemical as a disintegrant for tablets
L-HPC was independently developed by Shin-Etsu Chemical as a disintegrant for tablets
AstraZeneca Pharma India discontinues manufacturing of Imdur
The products will be manufactured in Goa India and marketed & distributed in Australian markets
Alkem Medtech to acquire 100% stake of Bombay Ortho
USFDA inspection at Emcure Pharmaceuticals API facility
Offers affordable, high-quality solutions for diabetes care
Akums Drugs & Pharmaceuticals has launched Dapagliflozin + Pioglitazone tablets, a dual-action therapy for diabetes management
The company will showcase groundbreaking innovations from its Pharma and Nutrition divisions, highlighting key ingredients and formulations designed to support holistic well-being
Lisdexamfetamine Dimesylate is indicated for the treatment of Attention Deficit Hyperactivity Disorder in adults and pediatric patients aged six years and older
Olanzapine is indicated for the acute and maintenance treatment of schizophrenia and related psychotic disorders
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
